Kymera Therapeutics Presents Late-Breaking Preclinical Data on IRAK4 Degrader KT-474 at IMMUNOLOGY2021™ Annual Meeting

Pat Purcell
Meeting Engagement

Matthew Durham
Omnidynamic Marketing

Amy Giles
Increasing Engagement

Stacey Gandler
Brand Nourishment

Bud Bilanich
Success Coach

Brenda Snow
Authentic Patient Voice

Suma Ramadas, PhD
Medical Affairs

Daniel Sontupe
Market Access

Matt Turner
Patient Affordability

Paul Theisen
Patient Acquisition

Frank Burrell
Scientific Storytelling

David Linetsky
Point-of-Care Marketing

Joey Cohen
Medication Adherence

Liz Kane
Impactful Strategy